Loading clinical trials...
Loading clinical trials...
Dissecting the Therapeutic Mechanism of an Effective Combination Treatment Targeting Neuromuscular Junction Dengeneration and Myosteatosis to Combat Sarcopenia
Conditions
Interventions
Low-magnitude High-frequency Vibration
β-hydroxy β-methylbutyrate (HMB) supplement
+1 more
Locations
3
Hong Kong
Evangelical Luthera Church Social Service - Hong Kong
Hong Kong, Hong Kong
The Chinese University of Hong Kong Jockey Club Centre for Osteoporosis Care and Control
Hong Kong, Hong Kong
The Chinese University of Hong Kong, Department of Orthopaedics and Traumatology, 1/F Li Ka Shing Outpatient Clinic (North), PWH
Hong Kong, Hong Kong
Start Date
January 12, 2023
Primary Completion Date
September 1, 2025
Completion Date
September 1, 2025
Last Updated
February 13, 2025
NCT06361511
NCT07519837
NCT06925880
NCT05884138
NCT06950125
NCT07412379
Lead Sponsor
Chinese University of Hong Kong
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions